
Closing the Screening Gap: How PathGroup’s GI Expertise and Guardant’s Shield™ Blood Test are Redefining Colorectal Cancer Detection
Colorectal cancer (CRC) remains the second leading cause of cancer-related death in the United States, yet it is highly treatable when detected early. Despite the








